Splanchnic cortisol production in dogs occurs primarily in the liver -: Evidence for substantial hepatic specific 11β hydroxysteroid dehydrogenase type 1 activity

被引:20
作者
Basu, Rita
Edgerton, Dale S.
Singh, Ravinder J.
Cherrington, Alan
Rizza, Robert A.
机构
[1] Mayo Clin, Coll Med, Dept Endocrinol Metab & Nutr, Rochester, MN 55905 USA
[2] Vanderbilt Univ, Med Ctr, Dept Physiol & Mol Biophys, Nashville, TN USA
[3] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA
关键词
D O I
10.2337/db06-0601
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Eight dogs underwent combined hepatic/portal vein catheterization and infusion of D4-cortisol in order to determine the relative contributions of the viscera and liver to splanchnic cortisol production. D4-cortisol concentrations progressively decreased from 2.6 +/- 0.1 to 2.4 +/- 0.1 to 1.7 +/- 0.1 mu g/dl (P < 0.001 by ANOVA) from hepatic artery to portal vein to hepatic vein, respectively, indicating 8 +/- 3 and 28 +/- 3% extraction across the viscera and liver, respectively. On the other hand, hepatic artery, portal vein, and hepatic vein cortisol concentrations did not differ (0.31 +/- 0.12 vs. 0.28 +/- 0.11 vs. 0.27 +/- 0.10 mu g/dl, respectively), indicating zero net cortisol balance. This meant that 1.0 +/- 0.1 mu g/min of cortisol was produced within the splanchnic bed, all of which occurred within the liver (1.2 0.1 mu g/min). On the other hand, visceral cortisol production did not differ from zero (-0.2 +/- 0.2 mu g/min; P < 0.001 vs. liver). Flux through the 110 hydroxysteroid dehydrogenase (HSD) type 1 pathway can be measured by determining the rate of conversion of D4-cortisol to D3-cortisol. D3-cortisol concentrations were lower in the portal vein than hepatic artery (0.45 +/- 0.03 vs. 0.48 +/- 0.02, respectively; P < 0.01) but did not differ in the portal vein and hepatic vein, indicating net uptake across the viscera but zero balance across the liver. D3-cortisol production with the viscera and liver averaged 0.2 +/- 0.1 mu g/min (P = NS vs. zero production) and 0.6 +/- 0.1 mu g/min (P < 0.001 vs. zero production; P < 0.001 vs. viscera production), respectively. We conclude that most, if not all, of splanchnic cortisol production occurs within the liver. Taken together, these data suggest that the high local cortisol concentrations generated via the 110 HSD type 1 pathway within the liver likely contribute to the regulation of hepatic glucose, fat, and protein metabolism.
引用
收藏
页码:3013 / 3019
页数:7
相关论文
共 27 条
[1]
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains [J].
Alberts, P ;
Nilsson, C ;
Selén, G ;
Engblom, LOM ;
Edling, NHM ;
Norling, S ;
Klingström, G ;
Larsson, C ;
Forsgren, M ;
Ashkzari, M ;
Nilsson, CE ;
Fiedler, M ;
Bergqvist, E ;
Öhman, B ;
Björkstrand, E ;
Abrahmsén, LB .
ENDOCRINOLOGY, 2003, 144 (11) :4755-4762
[2]
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice [J].
Alberts, P ;
Engblom, L ;
Edling, N ;
Forsgren, M ;
Klingström, G ;
Larsson, C ;
Rönquist-Nii, Y ;
Öhman, B ;
Abrahmsén, L .
DIABETOLOGIA, 2002, 45 (11) :1528-1532
[3]
Portal and peripheral cortisol in obese humans [J].
Aldhahi, W ;
Mun, E ;
Goldfine, AB .
DIABETOLOGIA, 2004, 47 (05) :833-836
[4]
Distinguishing the activities of 11β-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol [J].
Andrew, R ;
Smith, K ;
Jones, GC ;
Walker, BR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) :277-285
[5]
The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans [J].
Andrew, R ;
Westerbacka, J ;
Wahren, J ;
Yki-Järvinen, H ;
Walker, BR .
DIABETES, 2005, 54 (05) :1364-1370
[6]
Splanchnic cortisol production occurs in humans -: Evidence for conversion of cortisone to cortisol via the 11-β hydroxysteroid dehydrogenase (11β-HSD) type 1 pathway [J].
Basu, R ;
Singh, RJ ;
Basu, A ;
Chittilapilly, EG ;
Johnson, CM ;
Toffolo, G ;
Cobelli, C ;
Rizza, RA .
DIABETES, 2004, 53 (08) :2051-2059
[7]
Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans [J].
Basu, R ;
Singh, RJ ;
Basu, A ;
Chittilapilly, EG ;
Johnson, MC ;
Toffolo, G ;
Cobelli, C ;
Rizza, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07) :3919-3926
[8]
Effect of nutrient ingestion on total-body and splanchnic cortisol production in humans [J].
Basu, R ;
Singh, R ;
Basu, A ;
Johnson, CM ;
Rizza, RA .
DIABETES, 2006, 55 (03) :667-674
[9]
Light and electron microscopy localization of the 11ß-hydroxysteroid dehydrogenase type I enzyme in the rat [J].
Brereton, PS ;
van Driel, RR ;
Suhaimi, FBH ;
Koyama, K ;
Dilley, R ;
Krozowski, Z .
ENDOCRINOLOGY, 2001, 142 (04) :1644-1651
[10]
Does central obesity reflect ''Cushing's disease of the omentum''? [J].
Bujalska, IJ ;
Kumar, S ;
Stewart, PM .
LANCET, 1997, 349 (9060) :1210-1213